Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Candida albicans cells with increased cell wall chitin have reduced echinocandin susceptibility in vitro . The aim of this study was to investigate whether C. albicans cells with elevated chitin levels have reduced echinocandin susceptibility in vivo . BALB/c mice were infected with C. albicans cells with normal chitin levels and compared to mice infected with high-chitin cells. Caspofungin therapy was initiated at 24 h postinfection. Mice infected with chitin-normal cells were successfully treated with caspofungin, as indicated by reduced kidney fungal burdens, reduced weight loss, and decreased C. albicans density in kidney lesions. In contrast, mice infected with high-chitin C. albicans cells were less susceptible to caspofungin, as they had higher kidney fungal burdens and greater weight loss during early infection. Cells recovered from mouse kidneys at 24 h postinfection with high-chitin cells had 1.6-fold higher chitin levels than cells from mice infected with chitin-normal cells and maintained a significantly reduced susceptibility to caspofungin when tested in vitro . At 48 h postinfection, caspofungin treatment induced a further increase in chitin content of C. albicans cells harvested from kidneys compared to saline treatment. Some of the recovered clones had acquired, at a low frequency, a point mutation in FKS1 resulting in a S645Y amino acid substitution, a mutation known to confer echinocandin resistance. This occurred even in cells that had not been exposed to caspofungin. Our results suggest that the efficacy of caspofungin against C. albicans was reduced in vivo due to either elevation of chitin levels in the cell wall or acquisition of FKS1 point mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Based on previous research [66–68], to quantify the β-glucan and mannan content within the cell wall, the strains of WT, num11Δ/Δ, and num11Δ/NUM11N were cultivated overnight in 100 milliliters of fresh YPD liquid medium at 30°C and 200 rpm.”
From Mitochondrial anchor protein Num11 is key to pathogenicity of Candida albicans by affecting mitochondrial function and cell wall masking (2025) · cites this paper as [67]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Thus, mutations at these hot spots have been linked to a) impaired enzyme capacity, b) altered cell wall composition, i.e. reduced glucan and increased chit in content, c) increased cell wall thickness and d) impaired filamentation properties, which contribute to a lower growth rate in vitro and in vivo in drosophila and mouse models (31–33).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [33]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, mutations at these hot spots have been linked to a) impaired enzyme capacity, b) altered cell wall composition, i.e. reduced glucan and increased chit in content, c) increased cell wall thickness and d) impaired filamentation properties, which contribute to a lower growth rate in vitro and in vivo in drosophila and mouse models (31–33).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Echinocandin resistance in Candida has been linked to loss of fitness for homozygous Fks1p F641 and S645 mutants of C. albicans and Fks2p S663P mutants of C. glabrata (31–33).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, conditions that increase cell wall chitin promote cell survival in the presence of echinocandin76,77, whereas calcineurin inhibitors reduce echinocandin tolerance (measured using MIC assays analyzed after 72 h)68,78.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [77]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,479
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,687
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131 · cited 1×
“and are effective against Candida isolates which are resistant to other antifungal drugs, such as azoles (16, 51, 54).”
BackgroundConserved Fungal LysM Effector Ecp6 Prevents Chitin-Triggered Immunity in Plants
de Jonge, R., Peter van Esse, H., Kombrink, A., Shinya, T., Desaki, Y., Bours, R., van der Krol, S., Shibuya, N., Joosten, M. H. A. J., & Thomma, B. P. H. J. (2010) · Science · doi:10.1126/science.1190859 · Cited by 777
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698
Resistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · cited 3×
“S645Y is a common mutation in Fks1 HS1 associated with decreased sensitivity to echinocandins (50, 51).”
BackgroundChitin synthesis and fungal pathogenesis
Lenardon, M. D., Munro, C. A., & Gow, N. A. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.002 · Cited by 502
Self-citationStimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445 · cited 10×
“albicans strains with FKS1 hot-spot mutations have increased chitin content compared to wild-type strains (4, 70).”
BackgroundMethodResultSelf-citationPark, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Research works printed but not linked: 2
- 10.1080/mmy.39.1.1.8-0 · DOI · Paper page
- 10.1128/mmbr.61.2.170-192.1997 · doi:10.1128/mmbr.61.2.170-192.1997 · Paper page
Cited by
The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species
Garcia-Rubio, R., de Oliveira, H. C., Rivera, J., & Trevijano-Contador, N. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02993 · Cited by 917
“Strains with elevated levels of chitin in its cell wall also show an echinocandin resistant profile as revealed in a systematic in vivo infection model of candidiasis (Lee et al., 2012).”
BackgroundAntifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“albicans infection (Lee et al. 2012).”
BackgroundEchinocandin resistance in Candida.
Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374
“mutant strains with elevated chitin content have been shown to be less susceptible to echinocandins in vitro [30, 31, 35] and in an animal model [36].”
Ene, I. V., Adya, A. K., Wehmeier, S., Brand, A. C., MacCallum, D. M., Gow, N. A. R., & Brown, A. J. P. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01813.x · Cited by 313
“Glucosamine, glucose and mannose contents were then determined by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) in a carbohydrate analyser system from Dionex (Surrey, UK) (Lee et al., 2011), using hydrolysed samples from three independent biological replicates, each with…”
MethodSelf-citationMechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313
Echinocandin resistance: an emerging clinical problem?
Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299
Fungal Chitin Dampens Inflammation through IL-10 Induction Mediated by NOD2 and TLR9 Activation
Wagener, J., Malireddi, R. K. S., Lenardon, M. D., Köberle, M., Vautier, S., MacCallum, D. M., Biedermann, T., Schaller, M., Netea, M. G., Kanneganti, T.-D., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004050 · Cited by 289
“albicans cells with high chitin levels in their cell wall survive exposure to caspofungin in a mouse infection model [8], and that mice inoculated with high-chitin cells do not exhibit the inflammation-based pathology of the kidney that is characteristic of infection with C.”
BackgroundSelf-citationVirulence Factors in Candida species
Staniszewska, M. (2020) · Current Protein & Peptide Science · doi:10.2174/1389203720666190722152415 · Cited by 279
Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels
Brown, A. J. P., Brown, G. D., Netea, M. G., & Gow, N. A. R. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.07.001 · Cited by 258
Self-citationAntimicrobial Peptides: a New Frontier in Antifungal Therapy
Buda De Cesare, G., Cristy, S. A., Garsin, D. A., & Lorenz, M. C. (2020) · mBio · doi:10.1128/mbio.02123-20 · Cited by 231
“Increased content of chitin in the wall has also been linked with resistance to echinocandin drugs (143).”
BackgroundCosta-de-Oliveira, S., & Rodrigues, A. G. (2020) · Microorganisms · doi:10.3390/microorganisms8020154 · Cited by 229
Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin
Walker, L. A., Gow, N. A. R., & Munro, C. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-12 · Cited by 214
“albicans, both in vitro and in vivo (7, 41, 42).”
BackgroundSelf-citationDifferential Adaptation of Candida albicans In Vivo Modulates Immune Recognition by Dectin-1
Marakalala, M. J., Vautier, S., Potrykus, J., Walker, L. A., Shepardson, K. M., Hopke, A., Mora-Montes, H. M., Kerrigan, A., Netea, M. G., Murray, G. I., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003315 · Cited by 202
“albicans with Calcoflour White and CaCl2 induces high-chitin levels (Figure 7E) which can be maintained in vivo by treating mice with caspofungin [22].”
BackgroundMethodSelf-citationSchwarzmüller, T., Ma, B., Hiller, E., Istel, F., Tscherner, M., Brunke, S., Ames, L., Firon, A., Green, B., Cabral, V., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004211 · Cited by 191
“albicans demonstrate a role for chitin in regulating cell wall susceptibility to CF [108,109].”
BackgroundCandida albicans, plasticity and pathogenesis
Poulain, D. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.813904 · Cited by 173
“A deficit in glucans resulting from the action of echinocandin antifungals, which target the enzyme responsible for their synthesis, makes the cell wall fragile and will be compensated for by the increased synthesis of chitin (Lee et al., 2012).”
BackgroundThe fungal cell wall as a target for the development of new antifungal therapies
Cortés, J. C. G., Curto, M.-Á., Carvalho, V. S. D., Pérez, P., & Ribas, J. C. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.008 · Cited by 170
Candida albicans and Candida glabrata : global priority pathogens
Katsipoulaki, M., Stappers, M. H. T., Malavia-Jones, D., Brunke, S., Hube, B., & Gow, N. A. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00021-23 · Cited by 180
“In C. albicans , these mutations occur in two “hot spots” (HS) in the CaFKS1 gene rather than in CaFKS2 and CaFKS3 , while in C. glabrata , HS mutations that effect echinocandin MICs occur in both, CgFKS1 and (more commonly) CgFKS2 (99, 126, 127).”
BackgroundSelf-citationResistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Maubon, D., Garnaud, C., Calandra, T., Sanglard, D., & Cornet, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3404-7 · Cited by 162
García‐Effrón, G. (2020) · Journal of Fungi · doi:10.3390/jof6040262 · Cited by 143
A review of Candida species causing blood stream infection
Giri, S., & Kindo, A. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.99484 · Cited by 127
Hall, R. A., Bates, S., Lenardon, M. D., MacCallum, D. M., Wagener, J., Lowman, D. W., Kruppa, M. D., Williams, D. L., Odds, F. C., Brown, A. J. P., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003276 · Cited by 128
“Hydrolysed samples were washed and resuspended in water to a concentration of 10 mg/ml and 1:10 dilutions analysed by HPLC as described previously [56] and the relative proportions of sugars in the cell wall calculated.”
MethodSelf-citationBranco, J., Miranda, I. M., & Rodrigues, A. G. (2023) · Journal of Fungi · doi:10.3390/jof9010080 · Cited by 164
Wagener, J., MacCallum, D. M., Brown, G. D., & Gow, N. A. R. (2017) · mBio · doi:10.1128/mbio.01820-16 · Cited by 122
Self-citationHeilmann, C. J., Sorgo, A. G., Mohammadi, S., Sosinska, G. J., de Koster, C. G., Brul, S., de Koning, L. J., & Klis, F. M. (2013) · Eukaryotic Cell · doi:10.1128/ec.00278-12 · Cited by 122
“These strains also exhibited a strongly increased chitin content, which has been shown to be leading to a higher resistance to caspofungin in vivo (45).”
BackgroundEchinocandins: production and applications
Emri, T., Majoros, L., Tóth, V., & Pócsi, I. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-4761-9 · Cited by 123
“2008), and the increased chitin content also conferred echinocandin resistance in vivo (Lee et al. 2012).”
BackgroundChen, L., Yue, Q., Zhang, X., Xiang, M., Wang, C., Li, S., Che, Y., Ortiz‐López, F. J., Bills, G. F., Liu, X., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-339 · Cited by 113
“albicans [13-15].”
Zeise, K. D., Woods, R. J., & Huffnagle, G. B. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00323-20 · Cited by 97
“Compared with the yeast form, hyphae are associated with elevated cell wall chitin (191), which is important for immune evasion and as well as resistance to echinocandin antifungals such as caspofungin (87).”
BackgroundThe eagle effect and antibiotic-induced persistence: two sides of the same coin?
Prasetyoputri, A., Jarrad, A. M., Cooper, M. A., & Blaskovich, M. A. T. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.10.007 · Cited by 101
Elucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar-Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 100
Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99
“contents are less susceptible to echinocandins both in vitro [92, 93, 96, 97] and in vivo [98].”
Rueda, C., Cuenca‐Estrella, M., & Zaragoza, Ó. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00946-13 · Cited by 120
“In addition, increases in chitin levels have been related to a decrease of virulence in a murine model (21).”
BackgroundInfluentialPosteraro, B., Torelli, R., Vella, A., Leone, P. M., Angelis, G. D., Carolis, E. D., Ventura, G., Sanguinetti, M., & Fantoni, M. (2020) · Journal of Fungi · doi:10.3390/jof6030163 · Cited by 107
“Although non-FKS-mediated echinocandin resistance has been reported [46,47], phenotypic resistance (MICs above CLSI breakpoints) to all three echinocandins is uniquely attributable to the presence of mutations in hot spots of both FKS1 and its paralog FKS2 [48], which results in attenuated echinocandin activity [49].”
BackgroundGarcía-Valtanen, P., Guzman‐Genuino, R. M., Williams, D. L., Hayball, J. D., & Diener, K. R. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.13 · Cited by 114
Fungal cell wall: An underexploited target for antifungal therapies
Ibe, C., & Munro, C. A. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009470 · Cited by 96
“albicans cells with elevated chitin content in the wall are less susceptible to caspofungin treatment in vitro and in vivo [30].”
BackgroundSelf-citationWalker, L. A., Lee, K. K., Munro, C. A., & Gow, N. A. R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00862-15 · Cited by 100
Self-citationMunro, C. A. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407678-5.00004-0 · Cited by 104
Self-citationFungal Cell Wall Proteins and Signaling Pathways Form a Cytoprotective Network to Combat Stresses
Ibe, C., & Munro, C. A. (2021) · Journal of Fungi · doi:10.3390/jof7090739 · Cited by 98
Self-citationDrug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
Murphy, S. E., & Bicanic, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759408 · Cited by 83
Yang, F., Zhang, L., Wakabayashi, H., Myers, J., Jiang, Y., Cao, Y., Jimenez-Ortigosa, C., Perlin, D. S., & Rustchenko, E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00071-17 · Cited by 81
“compared to cells with normal levels of chitin (18).”
BackgroundAntifungal drug resistance in Candida species
Morace, G., Perdoni, F., & Borghi, E. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.09.002 · Cited by 80
“These strains, displaying a reduced susceptibility to echinocandins, showed mutations in the FKS genes (FKS1, FKS2 and FKS3) that correlated with amino acid substitutions in the 1,3-b-Dglucan synthase, the target of the echinocandins [5,7–10,12, 31–44].”
BackgroundBeyond the wall:Candida albicans secret(e)s to survive
Sorgo, A. G., Heilmann, C. J., Brul, S., de Koster, C. G., & Klis, F. M. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12049 · Cited by 74
“It is well known that wall stress leads to reinforcement of the cell wall with chitin, a minor but important component, through the activation of chitin synthases, resulting in increased stress resistance (Lee et al., 2012).”
BackgroundLi, Q., Zhao, Y., Zhu, X., & Xie, Y. (2021) · LWT · doi:10.1016/j.lwt.2021.111985 · Cited by 77
Dressed to impress: impact of environmental adaptation on the Candida albicans cell wall
Hall, R. A. (2015) · Molecular Microbiology · doi:10.1111/mmi.13020 · Cited by 73
“Interestingly, treatment with the echinocandin class of antifungals promotes chitin synthesis to compensate for the reduced glucan content in the cell wall (Lee et al., 2012).”
BackgroundGow, N. A. R., & Netea, M. G. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0462 · Cited by 87
“Such chitin-rich cells may be less inflammatory in vivo, thus limiting the immune response required for their elimination by the immune system [17].”
BackgroundSelf-citationLackner, M., Tscherner, M., Schaller, M., Kuchler, K., Mair, C., Sartori, B., Istel, F., Arendrup, M. C., & Lass-Flörl, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00123-14 · Cited by 67
“and elevated chitin levels in fungal cell wall (35).”
BackgroundTipping the balance both ways: drug resistance and virulence in Candida glabrata
Vale-Silva, L. A., & Sanglard, D. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov025 · Cited by 67
“Fungal factor(s) critical for this negative interaction are starting to be firmly identified (Slater et al. 2011; Lee et al. 2012).”
Briard, B., Rasoldier, V., Bomme, P., ElAouad, N., Guerreiro, C., Chassagne, P., Muszkieta, L., Latgé, J.-P., Mulard, L., & Beauvais, A. (2017) · The ISME Journal · doi:10.1038/ismej.2017.32 · Cited by 66
“fumigatus responds to diRhls in a way which is very similar to any response to environmental molecules including antifungals targeting cell wall such as echinocandins, calcofluor white or congo red (Ram and Klis, 2006; Perlin, 2011; Lee et al., 2012).”
BackgroundChen, Z., Martinez, D. A., Gujja, S., Sykes, S. M., Zeng, Q., Szaniszlo, P. J., Wang, Z., & Cuomo, C. A. (2014) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.009241 · Cited by 75
Caspofungin Induced Cell Wall Changes of Candida Species Influences Macrophage Interactions
Walker, L. A., & Munro, C. A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00164 · Cited by 70
“albicans cells with elevated chitin contents have also been shown to be less susceptible to caspofungin in a murine model of systemic infection (Lee et al., 2012).”
BackgroundMethodSelf-citationLinking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 77
“This inhibition results in the disruption of the synthesis of the carbohydrate β-1,3-glucan, a major component of the fungal cell wall [122].”
BackgroundMedically Important Fungi Respond to Azole Drugs: An Update
Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 69
Duvenage, L., Walker, L. A., Bojarczuk, A., Johnston, S. A., MacCallum, D. M., Munro, C. A., & Gourlay, C. W. (2019) · mBio · doi:10.1128/mbio.02535-18 · Cited by 61
Self-citationCaspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes
Song, J., & Stevens, D. A. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1068271 · Cited by 65
“…to casofungin has been associated with increased chitin synthesis, and overexpression of RER1 (regulator of echinocandin resistance) and the CDR2 efflux pump genes (Cota et al., 2008; Lee et al., 2012; Paderu et al., 2004; Perlin, 2007; Schuetzer-Muehlbauer et al., 2003; Walker et al., 2013).”
BackgroundYang, F., Kravets, A., Bethlendy, G., Welle, S., & Rustchenko, E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00516-13 · Cited by 60
Rueda, C., Puig-Asensio, M., Guinea, J., Almirante, B., Cuenca-Estrella, M., Zaragoza, O., Padilla, B., Muñoz, P., Guinea, J., Paño Pardo, J. R., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.09.016 · Cited by 58
Synergy of the antibiotic colistin with echinocandin antifungals in Candida species
Zeidler, U., Bougnoux, M.-E., Lupan, A., Helynck, O., Doyen, A., Garcia, Z., Sertour, N., Clavaud, C., Munier-Lehmann, H., Saveanu, C., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks538 · Cited by 58
Shahina, Z., El-Ganiny, A. M., Minion, J., Whiteway, M. S., Sultana, T., & Dahms, T. E. S. (2018) · Fungal Biology and Biotechnology · doi:10.1186/s40694-018-0046-5 · Cited by 59
“A suspension (OD600 = 0.001) of C. albicans (2.2 × 105 cells/mL) in YPD was added, with appropriate positive (amphotericin B) and negative (Candida only in media) controls and a blank (CNB oil in media) included.”
BackgroundInfluentialThe effect of antifungal resistance development on the virulence of Candida species
Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 78
“In addition, echinocandin treatment can also cause the unmasking of β-1,3-glucan, allowing more effective immune recognition by the host organism (Lee et al. 2012, Lewis et al. 2012).”
Protein kinase A and fungal virulence: A sinister side to a conserved nutrient sensing pathway
Fuller, K. K., & Rhodes, J. C. (2012) · Virulence · doi:10.4161/viru.19396 · Cited by 53
“Important fungal resistance mechanisms to these drugs may include the induction of salvage pathways that promote chitin synthesis to preserve cell wall stability.(121,122) The major conserved cell wall-integrity pathway in fungi is the Protein Kinase C-MAP Kinase (MAPK) pathway, and defects in MAPK signaling lead to h…”
BackgroundKim, J.-S., Lee, K.-T., Lee, M. H., Cheong, E., & Bahn, Y.-S. (2021) · mBio · doi:10.1128/mbio.02729-21 · Cited by 53
“Chitin and chitosan are fungal cell wall components that, along with glucans and mannoproteins, contribute to resistance of fungi to antifungal drugs (39).”
BackgroundSelf-citationPolvi, E. J., Averette, A. F., Lee, S. C., Kim, T., Bahn, Y., Veri, A. O., Robbins, N., Heitman, J., & Cowen, L. E. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006350 · Cited by 56
Lee, K. K., Kubo, K., Abdelaziz, J. A., Cunningham, I., de Silva Dantas, A., Chen, X., Okada, H., Ohya, Y., & Gow, N. A. R. (2018) · The Cell Surface · doi:10.1016/j.tcsw.2018.09.001 · Cited by 52
“All positive transformations were confirmed by the DNA sequencing analysis as previously described (Lee et al., 2012).”
BackgroundMethodInfluentialSelf-citationShields, R. K., Kline, E. G., Healey, K. R., Kordalewska, M., Perlin, D. S., Nguyen, M. H., & Clancy, C. J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01692-18 · Cited by 51
“Non-FKS mediated echinocandin resistance is uncommon but has been reported (7, 8).”
BackgroundNew developments and directions in the clinical application of the echinocandins
Chang, C. C., Slavin, M. A., & Chen, S. C. A. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1916-3 · Cited by 56
Papp, C., Kocsis, K., Tóth, R., Bodai, L., Willis, J. R., Ksiezopolska, E., Lozoya-Pérez, N. E., Vágvölgyi, C., Mora Montes, H., Gabaldón, T., et al. (2018) · mSphere · doi:10.1128/msphere.00547-18 · Cited by 50
“Alterations in the chitin content of certain strains of different Candida species also contribute to increased MIC values to echinocandins (35).”
BackgroundThe puzzling construction of the conidial outer layer of Aspergillus fumigatus
Valsecchi, I., Dupres, V., Michel, J., Duchateau, M., Matondo, M., Chamilos, G., Saveanu, C., Guijarro, J. I., Aimanianda, V., Lafont, F., et al. (2019) · Cellular Microbiology · doi:10.1111/cmi.12994 · Cited by 46
“Interestingly, Candida albicans cells with increased levels of cell wall chitin show reduced echinocandin susceptibility in vitro (Lee et al., 2012).”
BackgroundImplication of Candida parapsilosis FKS1 and FKS2 Mutations in Reduced Echinocandin Susceptibility
Martí-Carrizosa, M., Sánchez-Reus, F., March, F., Cantón, E., & Coll, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04922-14 · Cited by 46
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
Lewis, R. E., Viale, P., & Kontoyiannis, D. P. (2012) · Virulence · doi:10.4161/viru.20746 · Cited by 46
“The investigators were able to demonstrate that chitin purified from Candida albicans cell wall blocked Dectin-1 mediated recognition of human peripheral blood mononuclear cells and murine macrophages, leading to significant reductions in cytokine production.(76) Hence, chitin may be a signature of “less invasive” for…”
BackgroundFernandes, C., Gow, N. A. R., & Gonçalves, T. (2016) · Fungal Biology Reviews · doi:10.1016/j.fbr.2016.03.002 · Cited by 49
Self-citationKalem, M. C., Subbiah, H., Leipheimer, J., Glazier, V. E., & Panepinto, J. C. (2021) · mBio · doi:10.1128/mbio.03225-20 · Cited by 46
“It has been shown that increased cell wall chitin content contributes to caspofungin resistance (17, 18).”
BackgroundStanford, F. A., & Voigt, K. (2020) · Genes · doi:10.3390/genes11111296 · Cited by 46
Cell wall stress induces alternative fungal cytokinesis and septation strategies
Walker, L. A., Lenardon, M. D., Preechasuth, K., Munro, C. A., & Gow, N. A. R. (2013) · Journal of Cell Science · doi:10.1242/jcs.118885 · Cited by 42
“This stimulation of chitin synthesis protects C. albicans from an otherwise lethal concentration of caspofungin (Walker et al., 2008; Lee et al., 2012), and is capable of restoring viability to cells, even in the absence of Chs1 and Chs3, through formation of septa, which are dependent on the…”
BackgroundSelf-citationHuang, L., Zhang, J., Song, T., Yuan, L., Zhou, J., Yin, H., He, T., Gao, W., Sun, Y., Hu, X., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.03.010 · Cited by 42
Goldman, D. L., & Vicencio, A. G. (2012) · mBio · doi:10.1128/mbio.00056-12 · Cited by 49
“Though the primary role of chitin appears to be related to its role in structural integrity (including responses to environmental changes and replication), other roles have been hypothesized, including epithelial adhesion (1, 2), linkage between the cell wall and capsule (3), and antifungal resistance (4).”
BackgroundPianalto, K. M., Billmyre, R. B., Telzrow, C. L., & Alspaugh, J. A. (2019) · Genetics · doi:10.1534/genetics.119.302290 · Cited by 41
Potential Microbiological Effects of Higher Dosing of Echinocandins
Steinbach, W. J., Lamoth, F., & Juvvadi, P. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ725 · Cited by 41
Echinocandin Resistance in Candida Species: a Review of Recent Developments
Wiederhold, N. P. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0549-2 · Cited by 48
Chew, S. Y., Ho, K. L., Cheah, Y. K., Sandai, D., Brown, A. J. P., & Than, L. T. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133172 · Cited by 40
Alanazi, H., Semlali, A., Perraud, L., Chmielewski, W., Zakrzewski, A., & Rouabhia, M. (2014) · BioMed Research International · doi:10.1155/2014/963156 · Cited by 38
“albicans cells with a high level of chitin reportedly reduced susceptibility to antifungi such as caspofungin and echinocandins [47].”
BackgroundBiofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 48
Garcia-Rubio, R., Hernandez, R. Y., Clear, A., Healey, K. R., Shor, E., & Perlin, D. S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.702779 · Cited by 35
“For instance, the C. glabrata slt21 strain was shown to have decreased tolerance to several cell wall damaging agents, such as congo red, CFW, and micafungin (Miyazaki et al., 2010).”
BackgroundSuchodolski, J., Derkacz, D., Muraszko, J., Panek, J. J., Jezierska, A., Łukaszewicz, M., & Krasowska, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040314 · Cited by 35
“This effect is a defensive mechanism that makes the fungus resistant to caspofungin [14,56].”
BackgroundTargeting Candida spp. to develop antifungal agents
Salci, T. P., Negri, M., Abadio, A. K. R., Svidzinski, T. I. E., & Kioshima, É. S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.003 · Cited by 39
Co-recognition of β-glucan and chitin and programming of adaptive immunity to Aspergillus fumigatus
Amarsaikhan, N., & Templeton, S. P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00344 · Cited by 37
da Silva Dantas, A., Nogueira, F., Lee, K. K., Walker, L. A., Edmondson, M., Brand, A. C., Lenardon, M. D., & Gow, N. A. R. (2021) · Journal of Cell Science · doi:10.1242/jcs.258889 · Cited by 31
Self-citationFernandes, C., Anjos, J., Walker, L. A., Silva, B. M. A., Cortes, L., Mota, M., Munro, C. A., Gow, N. A. R., & Gonçalves, T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02647-13 · Cited by 42
“albicans cells with a high chitin content also have reduced echinocandin susceptibility both in vivo and in vitro (5).”
BackgroundSelf-citationDelgado, J., Owens, R. A., Doyle, S., Asensio, M. A., & Núñez, F. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7706-2 · Cited by 35
“Echinocandins induce compensatory increases in chitin synthesis, which confers resistance in Candida spp. (Cota et al. 2008; Lee et al. 2012).”
AFM combined to ATR-FTIR reveals Candida cell wall changes under caspofungin treatment
Quilès, F., Accoceberry, I., Couzigou, C., Francius, G., Noël, T., & El‐Kirat‐Chatel, S. (2017) · Nanoscale · doi:10.1039/c7nr02170d · Cited by 36
Xu, J., Luo, Y., Wang, J., Tu, W., Yi, X., Xu, X., Song, Y., Tang, Y., Hua, X., Yu, Y., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1125676 · Cited by 48
“It has been reported that some Candida species, including Candida albicans, Candida tropicalis, Candida parapsilosis, and Candida guilliermondii, depend on an elevated chitin level for conferring their resistance to antifungal drugs like caspofungin or echinocandin (Lee et al., 2012; Walker et al., 2013).”
BackgroundImtiaz, T., Lee, K. K., Munro, C. A., MacCallum, D. M., Shankland, G. S., Johnson, E. M., MACGREGOR, M. S., & Bal, A. M. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045047-0 · Cited by 37
Self-citationJaber, Q. Z., Bibi, M., Księżopolska, E., Gabaldón, T., Berman, J. G., & Fridman, M. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00813 · Cited by 35
Rodríguez-Castaño, G. P., Rosenau, F., Ständker, L., & Firacative, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030789 · Cited by 38
“However, some experiments on the evolution of resistance to peptides have observed a decreased susceptibility to AMPs via mutations in a single gene or in membrane-related resistance mechanisms, for example, a reduced cell wall with a negative charge through mutations in different genes [20,34,35].”
BackgroundChilders, D. S., Avelar, G. M., Bain, J. M., Larcombe, D. E., Pradhan, A., Budge, S., Heaney, H., & Brown, A. J. P. (2019) · Current topics in microbiology and immunology · doi:10.1007/82_2019_182 · Cited by 36
Li, R., Zhu, L., Liu, D., Wang, W., Zhang, C., Jiao, S., Wei, J., Ren, L., Zhang, Y., Gou, X., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119253 · Cited by 32
Transcriptional and translational landscape of Candida auris in response to caspofungin
Zamith-Miranda, D., Amatuzzi, R. F., Munhoz da Rocha, I. F., Martins, S. T., Lucena, A. C. R., Vieira, A. Z., Trentin, G., Almeida, F., Rodrigues, M. L., Nakayasu, E. S., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.09.007 · Cited by 29
“described that in response to caspofungin, the cells increased the chitin content and b-1,3-glucan become more exposed on the cell surface [46,47,62].”
BackgroundAvramovska, O., & Hickman, M. A. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400752 · Cited by 28
Abdullah, T., Gzara, L., Simonetti, G., Alshahrie, A., Salah, N. A., Morganti, P., Chianese, A., Fallahi, A., Tamayol, A., Bencherif, S. A., et al. (2018) · Materials · doi:10.3390/ma11030451 · Cited by 28
“Similarity in chemical composition between chitin and the fungi wall could also be another reason for the inferior antifungal performance of the pure and hybrid fibrous scaffolds [43].”
BackgroundAucklandia lappa Causes Cell Wall Damage in Candida albicans by Reducing Chitin and (1,3)-β-D-Glucan
Lee, H.-S., & Kim, Y. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2002.02025 · Cited by 30
“In fact, it is reported that cells respond to cell wall stress by increasing the chitin levels in the cell wall to strengthen it [22].”
Background
Metadata
- Authors
- Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A.
- Affiliations
- University of Aberdeen (GB)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-01
- Volume
- 56
- Issue
- 1
- Pages
- 208-217
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3256049
- OpenAlex
- W2127997803
- Cited by
- 209
- References
- 77
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 13 · 2023: 11 · 2022: 9 · 2021: 18 · 2020: 20 · 2019: 16 · 2018: 14 · 2017: 15 · 2016: 12 · 2015: 15 · 2014: 19 · 2013: 16 · 2012: 12
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (086827, 080088)
- University of Aberdeen
- Chinese Academy of Agricultural Sciences
- Biotechnology and Biological Sciences Research Council (BB/F00513X/1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida albicans, echinocandin resistance, caspofungin, FKS1 mutations, antifungal susceptibility, kidney fungal burden, fungal virulence
- MeSH terms
- Caspofungin, Animals, Antifungal Agents, Candida albicans, Candidiasis, Cell Wall, Chitin, DNA Mutational Analysis, Female, Fungal Proteins, Glucosyltransferases, Kidney, Mice, Inbred BALB C, Microbial Sensitivity Tests, Microscopy, Fluorescence, Mutation, Survival Rate, Amino Acid Substitution, Drug Resistance, Fungal, Mice, Echinocandins, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.